Emerging Views On Emerging Markets: JP Morgan Healthcare Conference (Part 1 of 2)
This article was originally published in PharmAsia News
Emerging markets continued to play a large role in company presentations during the industry’s largest investor conference. PharmAsia News takes a closer look.
You may also be interested in...
SHANGHAI - China could serve as the catalyst for a new model of dealmaking that emphasizes more flexible and strategic partnerships to drive R&D productivity, but only if Big Pharma is willing to take "calculated risks," according to Bayer Healthcare AG Chairman Jorg Reinhardt
In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the recent Morgan Stanley Global Healthcare Conference in New York ('Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference,' PharmAsia News, Sept. 22, 2011). For this profile, we zoom in on the Bank of America Merrill Lynch Global Healthcare Conference, held Sept. 15-16 in London.
Medtronic's growth acceleration plan calls for optimizing its research and development investments, accelerating globalization efforts, and improving execution of all initiatives, according to newly installed CEO Omar Ishrak